Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

Similar articles for PubMed (Select 8634569)

1.
2.

The rationale for a spine registry.

Röder C, Müller U, Aebi M.

Eur Spine J. 2006 Jan;15 Suppl 1:S52-6. Epub 2005 Nov 16. Review.

3.

Observational studies are complementary to randomized controlled trials.

Grootendorst DC, Jager KJ, Zoccali C, Dekker FW.

Nephron Clin Pract. 2010;114(3):c173-7. doi: 10.1159/000262299. Epub 2009 Nov 28.

4.

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.

Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C.

Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. Review.

5.

What observational studies can offer decision makers.

Black N.

Horm Res. 1999;51 Suppl 1:44-9.

PMID:
10393491
6.

The WHO antenatal care randomised controlled trial: rationale and study design.

Villar J, Bakketeig L, Donner A, al-Mazrou Y, Ba'aqeel H, Belizán JM, Carroli G, Farnot U, Lumbiganon P, Piaggio G, Berendes H.

Paediatr Perinat Epidemiol. 1998 Oct;12 Suppl 2:27-58.

PMID:
9805722
7.

Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.

Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey Smith G.

Health Technol Assess. 2001;5(33):1-56. Review.

8.

A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies.

MacLehose RR, Reeves BC, Harvey IM, Sheldon TA, Russell IT, Black AM.

Health Technol Assess. 2000;4(34):1-154. Review.

9.

The respective roles of controlled clinical trials and cohort monitoring studies in the pre- and postmarketing assessment of drugs.

Vray M, Hamelin B, Jaillon P; Round Table No.2, Giens XX.

Therapie. 2005 Jul-Aug;60(4):339-44, 345-9. English, French.

PMID:
16268434
10.

Systematic review of outpatient services for chronic pain control.

McQuay HJ, Moore RA, Eccleston C, Morley S, Williams AC.

Health Technol Assess. 1997;1(6):i-iv, 1-135. Review.

11.
12.

Generalisability in economic evaluation studies in healthcare: a review and case studies.

Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A.

Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. Review.

13.

Data collection in clinical toxicology: are there too many variables?

Whyte IM, Buckley NA, Dawson AH.

J Toxicol Clin Toxicol. 2002;40(3):223-30. Review.

PMID:
12144195
14.

Procedures and methods of benefit assessments for medicines in Germany.

Bekkering GE, Kleijnen J.

Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.

PMID:
18987905
15.

Another look at observational studies in rehabilitation research: going beyond the holy grail of the randomized controlled trial.

Horn SD, DeJong G, Ryser DK, Veazie PJ, Teraoka J.

Arch Phys Med Rehabil. 2005 Dec;86(12 Suppl 2):S8-S15.

PMID:
16373136
16.

A critical synopsis of the diagnostic and screening radiology outcomes literature.

Blackmore CC, Black WC, Jarvik JG, Langlotz CP.

Acad Radiol. 1999 Jan;6 Suppl 1:S8-18.

PMID:
9891161
17.

Research and theory for Nursing and Midwifery: Rethinking the Nature of Evidence.

McCourt C.

Worldviews Evid Based Nurs. 2005;2(2):75-83.

PMID:
17040544
18.
19.

Methodology for the scientific evaluation of complementary and alternative medicine.

Hyland ME.

Complement Ther Med. 2003 Sep;11(3):146-53.

PMID:
14659376
20.

Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials.

King M, Nazareth I, Lampe F, Bower P, Chandler M, Morou M, Sibbald B, Lai R.

Health Technol Assess. 2005 Sep;9(35):1-186, iii-iv. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk